[PDF][PDF] Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G
are suggestive of a selective advantage but may also be due to a random founder effect. We …
are suggestive of a selective advantage but may also be due to a random founder effect. We …
[HTML][HTML] Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
…, N Storey, F Flaviani, A Alcolea-Medina… - The Lancet Public …, 2021 - thelancet.com
Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …
England. We aimed to investigate whether increases in the proportion of infections with this …
[HTML][HTML] Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
…, S Pickering, T Charalampous, A Alcolea-Medina… - Nature …, 2021 - nature.com
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …
[HTML][HTML] Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort …
…, N Storey, F Flaviani, A Alcolea-Medina… - The Lancet Infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March,
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
[HTML][HTML] Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre …
…, B Patel, T Charalampous, A Alcolea-Medina… - The Lancet …, 2021 - thelancet.com
Background Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone
of SARS-CoV-2 mass community testing, although their reduced sensitivity compared …
of SARS-CoV-2 mass community testing, although their reduced sensitivity compared …
[PDF][PDF] The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
…, D Aggarwal, SSY Ahmad, L Aigrain, A Alcolea-Medina… - Iscience, 2021 - cell.com
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating
global sequence data. Several variants within nucleocapsid and ORF3a epitopes have …
global sequence data. Several variants within nucleocapsid and ORF3a epitopes have …
[HTML][HTML] Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded …
T Charalampous, A Alcolea-Medina, LB Snell… - Genome medicine, 2021 - Springer
Background Clinical metagenomics (CMg) has the potential to be translated from a research
tool into routine service to improve antimicrobial treatment and infection control decisions. …
tool into routine service to improve antimicrobial treatment and infection control decisions. …
Broad neutralization of SARS-CoV-2 variants, including omicron, following breakthrough infection with Delta in COVID-19-vaccinated individuals
…, ZA Shalim, T Charalampous, A Alcolea-Medina… - Mbio, 2022 - Am Soc Microbiol
Numerous studies have shown that a prior SARS-CoV-2 infection can greatly enhance the
antibody response to COVID-19 vaccination, with this so called “hybrid immunity” leading to …
antibody response to COVID-19 vaccination, with this so called “hybrid immunity” leading to …
SARS-CoV-2 lineage B. 1.1. 7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study
…, A Alcolea-Medina… - BMJ open …, 2021 - bmjopenrespres.bmj.com
Background SARS-CoV-2 lineage B.1.1.7 has been associated with an increased rate of
transmission and disease severity among subjects testing positive in the community. Its impact …
transmission and disease severity among subjects testing positive in the community. Its impact …
[HTML][HTML] The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study
A Alcolea-Medina, LB Snell, C Alder… - Clinical Microbiology …, 2023 - Elsevier
… Author links open overlay panel Adela Alcolea-Medina 1 2 a , Luke B. Snell 1 3 a , Christopher
Alder 3 , Themoula … Alcolea-Medina, LB Snell, TGS Williams, R. Batra, C. Alder, et al. …
Alder 3 , Themoula … Alcolea-Medina, LB Snell, TGS Williams, R. Batra, C. Alder, et al. …